Navigation Links
Bausch + Lomb adquirirá Technolas Perfect Vision GmbH
Date:11/7/2012

ROCHESTER, Nueva York, y MÚNICH, 7 de noviembre del 2012 /PRNewswire/ -- Bausch + Lomb, empresa mundial de salud ocular, anunció hoy que ha ejercido su opción para adquirir todas las acciones en circulación y sin titulares de Technolas™ Perfect Vision GmbH (TPV), empresa líder de láser oftalmológico. Technolas Perfect Vision fue creada en el 2009 a través de un acuerdo empresario entre Bausch + Lomb y 20/10 PERFECT VISION AG para desarrollar y vender tecnologías avanzadas refractivas y de cataratas. Se espera que el acuerdo se cierre a fines de enero del 2013.

Bausch + Lomb y Technolas Perfect Vision suscribieron un acuerdo de promoción conjunta en septiembre del 2011, que también incluyó una opción para Bausch + Lomb de adquirir la empresa si se lograban ciertas metas. Desde ese momento, las empresas han aprovechado sus conocimientos refractivos y de cataratas combinados y sus capacidades comerciales para promover y fomentar el láser de femtosegundo VICTUS™, que es capaz de soportar intervenciones de cataratas y de córneas en una sola plataforma. En los últimos doce meses, la plataforma VICTUS recibió la aprobación de comercialización de las autoridades regulatorias de Europa y los Estados Unidos, y las empresas siguen presentando registraciones en otras partes del mundo al tiempo que aceleran la implementación.

"Nuestra adquisición de Technolas Perfect Vision representa un hito importante para Bausch + Lomb, pero tal vez sea más importante marcar lo que significa para los pacientes refractivos y de cataratas de todo el mundo", afirmó Brent Saunders, presidente y director ejecutivo de Bausch + Lomb. "El equipo de Technolas Perfect Vision ha creado una gran empresa y, desde mi perspectiva, los láseres oftálmicos más innovadores del sector".

"Nuestros sis
'/>"/>

SOURCE Bausch + Lomb
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Bausch + Lomb adquiere Technolas Perfect Vision GmbH
2. Bausch + Lomb to Acquire Technolas Perfect Vision GmbH
3. Bausch + Lomb übernimmt Technolas Perfect Vision GmbH
4. Bausch + Lomb prestes a adquirir a Technolas Perfect Vision GmbH
5. Farmers team with scientists to make the perfect rat trap
6. Nutrient and toxin all at once: How plants absorb the perfect quantity of minerals
7. Infrared vision in a cichlid fish
8. New study sheds light on how and when vision evolved
9. Military vision research symposium focuses on visual fallout from war
10. Deep-sea crabs seek food using ultraviolet vision
11. IdentiSys acquires the Identification, Security and Presentation Divisions of Mountainland Business Systems, a Utah based reseller
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/6/2015)... BOSTON and TELTOW, Germany ... the 2015 Siggraph Conference, SensoMotoric Instruments (SMI) ... augmented reality , based on Epson,s Moverio ... eye tracking platform. With this new solution, unprecedented quality ... multi-modal, hands-free interaction with context-sensitive displays. For the first ...
(Date:8/5/2015)... 5, 2015 The biosensors market is proving ... penetration into newer sectors, and development of devices resulting ... space has seen the entry of multiple participants each ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... of the Global Biosensors Market ( http://www.frost.com/nee9 ), ...
(Date:7/31/2015)... Den 10. internationale konference om Genomik (ICG-10, ... - 25. oktober i Shenzhen , ... i år. Siden starten i 2006 er ICB blevet ... og er en af de mest dynamiske, entusiastiske og ... nylige gennembrud og fremskridt inden for ,omik,-forskning, som yderligere ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... Consumers are more likely to change their behavior if ... what to do, according to a new study in ... nudge them along if you,re trying to encourage more ... especially if consumers pledge specific steps to promote the ...
... Bracelets and amulets are in the works at ... than items of mere adornment, the scientists and engineers ... as it were. mHealth is a rapidly growing ... your health through mobile devices. This approach can offer ...
... Scientists at The University of Nottingham say adverse side-effects caused ... could be controlled by what we eat. The research, ... the UK and Malaysia, indicates that natural variation in our ... on how we respond to quinine treatment. It appears that ...
Cached Biology News:Want to encourage eco-friendly behavior? Give consumers a nudge (Don't tell them what to do) 2Dartmouth research imparts momentum to mobile health 2Dartmouth research imparts momentum to mobile health 3Dartmouth research imparts momentum to mobile health 4Diet could combat adverse side-effects of quinine 2Diet could combat adverse side-effects of quinine 3
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/v7fdpx/argentina ) has ... Market - Growth, Trends & Forecasts (2014-2020)" report ... Sensors market is estimated at $0.17 billion by 2018 ... The near future will bring Biomedical sensors ... individual. These sensors can be set to trigger alerts ...
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cbgl72/middle_east_and ) has announced the ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Middle East & Africa Biomedical Sensors ... a CAGR of 3.26% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:8/31/2015)... MARLBOROUGH, Mass. , Aug. 31, 2015 /PRNewswire/ ... biotechnology company focused on discovering and developing innovative ... ophthalmology, today announced that the 30-day review period ... Drug (IND) for ocular indications with the U.S. ... the IND is now active. ...
(Date:8/31/2015)... , Aug. 31, 2015 FLX Bio, ... development of novel cancer immunotherapies, announced today that it ... Chief Executive Officer and William Ho , M.D., ... join an experienced management team led by veterans of ... , Ph.D., Chief Scientific Officer; Jay Powers , ...
Breaking Biology Technology:Argentina Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts 2014-2020 2Middle East & Africa Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts to 2020 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4
... Board and Management on Avigen,s February 11, 2009 Conference ... Fund, L.P. ("BVF"), today called for the management of ... certain fundamental questions BVF believes need to be answered ... strategic direction. Avigen announced in its January 14, ...
... nutrition retailer launches Max Crunch bar with ... help with protein digestion and assimilationANAHEIM, Calif., ... Sports Nutrition today announced the launch of ... introduced in the U.S. The collaboration between ...
... Israel, Feb. 10 Modigene Inc. (OTC Bulletin ... set the close of business on April 1, 2009 as ... Company,s 2009 Annual Meeting of Shareholders. Modigene currently anticipates ... 21, 2009 in Miami, Florida at a location to be ...
Cached Biology Technology:Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 2Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 3Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 4Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders 5Max Muscle Introduces First-Ever Probiotics Protein Bar 2Max Muscle Introduces First-Ever Probiotics Protein Bar 3Modigene Sets Record Date for Annual Meeting of Shareholders 2
... Clone/PAD: ZMD.283. Immunogen: Fusion protein ... Specific for ASIP/PAR-3 (atypical PKC isotype-specific ... antigen is not related to the ... Human Dog Xenopus (positive controls: Caco-2 ...
...
Request Info...
normal rat IgM AF647...
Biology Products: